Aptamer Details

Back to Search Results

SARS Coronavirus NTPase/Helicase (ES15-1) (ID# 7531)

SARS Coronavirus NTPase/Helicase
1.2 nM (reported value)
Binding Buffer (30 mM Trisƒ??HCl (pH 7.5), 150 mM NaCl, 1.5 mM MgCl2 , 2 mM dithiothreitol (DTT) and 1% (w/v) BSA) Termination Buffer (0.2 M EDTA, 0.2 M NaCl, and 20 mM HEPES (pH 7.4)) Buffer A (25 mM Trisƒ??HCl (pH 7.5), and 0.3 mM NaCl)
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.

Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.

Jang, K., et al. "Isolation of inhibitory RNA aptamers against severe acute respiratory syndrome (SARS) coronavirus NTPase/Helicase." Biochemical and Biophysical Research Communications, 366(2008): 738-744.

Have your aptamer oligo synthesized ORDER